• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Duloxetine
    4 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Cymbalta
    Eli Lilly
    RX
    partial basket chart
    Cymbalta

    SNRI. Duloxetine HCl 30 mg, 60 mg.
    CAPS: 7,14,28 x 30 mg, 60 mg.
    intial: 30 mg dly. maint: 60 mg dly.
    Ther. response: 2-4 wks aft. tmt. To
    discont: Taper by 1/2 dose (30 mg) dly
    or on alt. days. See lit.
    Major depress. episodes., Generalized
    anxiety dis., Neuropath. pain assoc.
    with diabet. periph. neuropathy.,
    fibromyalg., chron. muscoskeletal pain.
    C/I: Concom. use with MAOI,
    uncontrolled narrow-angle glaucoma.

    Dulox Teva 30 & 60 mg
    Abic
    RX
    partial basket chart
    Dulox Teva 30 & 60 mg

    SNRI. Duloxetine 30 , 60 mg.
    CAPS.:30. For diabet. peripher. neuropath.  pain: The usual dose is 60 mg ×1/d.
    For chron. musculoskel. pain and general. anxiety disord.: For most pts.
    60 mg ×1/d. Some pts. require an init. dose of Dulox Teva 30 mg ×1/d for one wk., and then the usual dose of
    60 mg ×1/d.
    For depression: Most pts. will receive 60 mg ×1/d. Some pts. require an init. dose of Dulox Teva 30 mg ×1/d for one wk., and then the usual dose of 60 mg ×1/d
    Elderly – The init. dose of 30 mg ×1/d for two wks., and only then consider incr. the dose to 60 mg ×1/d.
    Fibromyalgia: The init. dose of Dulox Teva is 30 mg ×1/d  for one wk., and then the usual dose of 60 mg ×1/d. In most cases, the effect of medication ther. with Dulox Teva is noticeab. after 2-4 wks. of tmt.
    See lit.
    Tmt. of major depressive episodes.
    Managem. of neuropath.pain associat. with diabet. peripher. neuropathy.
    Tmt. of generaliz. anxiety disord. (GAD).
    Manag. of fibromyalgia.
    Manag. of chron. muscoskel. pain when other therapies have failed or are
    contraindic. This has been establish. in studies in pts. with chron. low back pain (CLBP) and chron. pain due to osteoarthritis.
    C/I: Hypersens.
    Pts. with hep. dis.
    Pts.  with severe ren. dis..
    Concom. use with MAOI  includ. IV methylene blue and the antibiot.linezolid. MAOI should be discount. 14 d. before init.of the tmt. with duloxetine.
    Initiat. of MAOI should be start. at least 5 d. after discount. of the tmt. with duloxetine.
    Concom. use with thioridazine

    Duloxetine DR Teva
    Teva
    RX
    partial basket chart
    Duloxetine DR Teva

    SNRI. Duloxetine (as HCl) 20, 30, 60 mg.
    DR CAPS: 30 ×20mg, 30mg, 60mg.
    Major depres.disor. 60 mg/d.
    GAD: init. reccom. dose 30 mg ×1/d for
    1 week, may be incr. to 60 mg ×1/d.
    Max until: 120mg x 1/d.
    Diab. periph. neurop. pain: 60 mg x
    1/d; lower init., dose, grad. incr. in pts.
    with ren. impair.
    Fibromyal.: init. 30 mg x 1/d; for 1
    week, may be incr. to 60 mg ×1/d.
    Chron. musculoskel. pain: init. 30 mg
    start at 30 mg ×1/d for 1 week, may be
    incr. to 60 mg ×1/d.
    Tmt. of Major. depress. epis.; manag. of
    neurop. pain assoc. with diab. periph.
    neurop. Tmt. of GAD; Fibromyal.; Manag.
    of chron. muscoskel. pain when other ther.
    have fail.or are contra-ind.
    C/I: Hypersens. , Liver dis. result. in hep.
    impair., Sev. ren. impair., Pts. und. other
    medic. contain. duloxetine.
    Concom. use with MAOIs or within 14 d.
    after use MAOIs Init. of tmt. with MAOIs
    should be start. only on a 5th day elapse
    from stop. tmt. with Duloxetine.
    Concom. use with fluvoxamine,
    thioridazine, cimetidine, quinolone.
    Concom. use with ciprofloxacin or
    enoxacin Pts. with uncontr. narr.-ang.
    glauc.

    Yentreve
    Eli Lilly
    RX
    not in the basket chart
    Yentreve

    SNRI. Duloxetine (HCl) 20, 40 mg.
    CAPS: 7,14,28,56X 20, 40mg.
    Maint: 40 mg 2 x dly. Some pts. may
    benefit from initial tmt. of 20 mg 2 x
    dly for 2 wks bef. incr. to 40 mg 2 x dly.
    Ther. response: Within 2-4 wks. To
    discont. taper by 1/2 dose to either 40
    mg 1 x dly or 20 mg 2 x dly.
    Mod. to severe Stress Urinary Incontinence.
    C/I: Hypersens., hepat. impair., pregn.,
    lact. Not to be used in comb. with
    nonselect. irrevers. MAOI’s or CYP1A2
    inhibitors. See lit.

    CLOSE